What Does Entera Bio Ltd. Do?

Total employees19
HeadquartersJerusalem
Founded2010

Entera Bio Ltd. is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's proprietary oral drug delivery platform is designed to enable the absorption of large molecules and biologics in an oral form that are otherwise typically delivered via injection. Entera Bio's lead product candidates include EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. The company aims to provide more convenient and patient-friendly alternatives to existing injectable treatments.

Where Is Entera Bio Ltd.'s Headquarters?

HQ Function

Serves as the global headquarters, housing corporate leadership, research and development (R&D) laboratories, and administrative operations.

Notable Features:

Modern laboratory and office facilities supporting advanced biopharmaceutical research within the Minrav Building.

Work Culture:

A collaborative and innovative environment focused on scientific discovery and therapeutic development, characterized by a dedicated team aiming to advance oral drug delivery technologies.

HQ Significance:

Strategically located in Jerusalem, a growing hub for life sciences in Israel, providing access to skilled talent, research institutions, and a supportive biotech ecosystem.

Values Reflected in HQ: The facility's focus on R&D and advanced technology reflects Entera Bio's commitment to innovation, scientific rigor, and developing patient-centric therapeutic solutions.

Location:

While headquartered in Israel, Entera Bio's operations have a global reach primarily through its clinical trials, which may be conducted in various international locations to ensure diverse patient populations and meet regulatory requirements. The company also engages with the global investment community and seeks potential future commercialization partnerships on an international scale. Its therapeutic candidates are being developed to address medical needs for patients worldwide.

Street Address:

Kiryat Hadassah, Minrav Building – 5th Floor, P.O. Box 12158

City:

Jerusalem

State/Province:

Jerusalem District

Country:

Israel

Where Else Does Entera Bio Ltd. Operate Around the World?

No additional office locations available.

Buying Intent Signals for Entera Bio Ltd.

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Entera Bio Ltd.? Meet the Executive Team

As of April 2025, Entera Bio Ltd.' leadership includes:

Miranda Toledano - Chief Executive Officer, Director
Hillel Galitzer - Chief Operating Officer
Dana Gelbaum, Ph.D. - Chief Business Officer
Arthur M. Suckow, Ph.D. - Chief Technology Officer
Prof. Arnon Nagler, MD, MSc - Medical Director
Anat Tsour Segal, PhD - VP R&D

Who's Investing in Entera Bio Ltd.?

Entera Bio Ltd. has been backed by several prominent investors over the years, including:

Pontifax Late Stage Fund L.P.
Centillion Fund
D.N.A Biomedical Solutions Ltd.

What Leadership Changes Has Entera Bio Ltd. Seen Recently?

Hire3
Exits1

Over the past 12 months, Entera Bio has undertaken significant leadership restructuring, including the appointment of a new CEO, CBO, and CTO, and the departure of its former CEO. These changes aim to steer the company through its next phase of clinical development and strategic growth.

Departures

Spiros Jamas, Sc.D., Dr. Spiros Jamas departed from his role as Chief Executive Officer.

New Appointments:

Miranda Toledano, Miranda Toledano transitioned from CFO & CBO to become the new Chief Executive Officer.
Dana Gelbaum, Ph.D., Dr. Dana Gelbaum was appointed as the new Chief Business Officer.
Arthur M. Suckow, Ph.D., Dr. Arthur M. Suckow was appointed as the new Chief Technology Officer.

What Technology (Tech Stack) Is Used byEntera Bio Ltd.?

Discover the tools Entera Bio Ltd. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Entera Bio Ltd. Email Formats and Examples

Entera Bio likely utilizes common corporate email formats. While specific formats are not publicly confirmed by the company, patterns often involve combinations of the employee's first name, last name, or initials followed by '@enterabio.com'.

[first].[last]@enterabio.com

Format

miranda.toledano@enterabio.com

Example

85%

Success rate

What's the Latest News About Entera Bio Ltd.?

GlobeNewswireMarch 28, 2024

Entera Bio Reports Full Year 2023 Financial Results and Provides Business Update

Entera Bio announced its financial results for the full year ended December 31, 2023, and provided updates on its clinical programs, including progress on EB613 for osteoporosis and EB612 for hypoparathyroidism, highlighting plans for a Phase 2b study for EB613....more

GlobeNewswireFebruary 20, 2024

Entera Bio Announces First Patient Enrolled in Phase 1 Clinical Trial of Oral PTH (1-34) Formulation for the Treatment of Hypoparathyroidism

Entera Bio announced the enrollment of the first patient in its Phase 1 clinical trial for EB612, an oral formulation of human parathyroid hormone (1-34), or PTH, for the treatment of hypoparathyroidism....more

GlobeNewswireOctober 2, 2023

Entera Bio Appoints Arthur M. Suckow, Ph.D. as Chief Technology Officer

Entera Bio announced the appointment of Arthur M. Suckow, Ph.D., as its Chief Technology Officer, effective October 1, 2023. Dr. Suckow brings extensive experience in biopharmaceutical development and manufacturing to the role....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Entera Bio Ltd., are just a search away.